Mitchell Paul Levesque
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age.
Birkenmaier I, Maul L, Oyanguren I, Sorbe C, Fröhlich F, Schlapbach C, Heidemeyer K, Yawalkar N, Boehncke W, Ring H, Thyssen J, Egeberg A, Micheroli R, Thomsen S, Mainetti C, Cozzio A, Kündig T, Levesque M, Navarini A, Maul J. Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age. Arch Dermatol Res 2024; 316:654.
01.10.2024Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age.
01.10.2024Arch Dermatol Res 2024; 316:654
Birkenmaier Ion, Maul Lara Valeska, Oyanguren Iker, Sorbe Christina, Fröhlich Fabienne, Schlapbach Christoph, Heidemeyer Kristine, Yawalkar Nikhil, Boehncke Wolf-Henning, Ring Hans-Christian, Thyssen Jacob P, Egeberg Alexander, Micheroli Raphael, Thomsen Simon Francis, Mainetti Carlo, Cozzio Antonio, Kündig Thomas M, Levesque Mitchell Paul, Navarini Alexander A, Maul Julia-Tatjana
Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.
de Joode K, Mora A, van Schaik R, Zippelius A, van der Veldt A, Gerard C, Läubli H, Michielin O, von Moos R, Jörger M, Levesque M, Aeppli S, Mangana J, Mangas C, Trost N, Meyer S, Parvex S, Mathijssen R, Metaxas Y. Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma. J Immunother 2024; 47:190-194.
06.02.2024Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.
06.02.2024J Immunother 2024; 47:190-194
de Joode Karlijn, Mora Alfonso Rojas, van Schaik Ron H N, Zippelius Alfred, van der Veldt Astrid, Gerard Camille Léa, Läubli Heinz, Michielin Olivier, von Moos Roger, Jörger Markus, Levesque Mitchell Paul, Aeppli Stefanie, Mangana Johanna, Mangas Cristina, Trost Nadine, Meyer Stefan, Parvex Sandra Leoni, Mathijssen Ron H J, Metaxas Yannis
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
Amaral T, Pop O, Chatziioannou E, Sinnberg T, Niessner H, Zhao J, Ring S, Jörger M, Schroeder C, Armeanu-Ebinger S, Cozzio A, Leiter U, Thomas I, Jochum W, Garbe C, Forchhammer S, Levesque M, Mangana J, Hölzel M, Dummer R, Schürch C, Forschner A, Flatz L. EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy. J Am Acad Dermatol 2023; 89:1072-1074.
22.07.2023EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.
22.07.2023J Am Acad Dermatol 2023; 89:1072-1074
Amaral Teresa, Pop Oltin Tiberiu, Chatziioannou Eftychia, Sinnberg Tobias, Niessner Heike, Zhao Jing Hua, Ring Sandra Stephanie, Jörger Markus, Schroeder Christopher, Armeanu-Ebinger Sorin, Cozzio Antonio, Leiter Ulrike, Thomas Ioannis, Jochum Wolfram, Garbe Claus, Forchhammer Stephan, Levesque Mitchell Paul, Mangana Joanna, Hölzel Michael, Dummer Reinhard, Schürch Christian M, Forschner Andrea, Flatz Lukas